Friend erythroleukemia induced in mice by the spleen focus forming virus (SFFV) is a multi-step process. The pre-leukemic phase of the disease results from the abnormal activation of the Erythropoietin (Epo) receptor by the gp55 env gene product of SFFV. Later in disease progression, the emergence of leukemic clones is associated with recurrent genetic events, in particular the activation of the expression of SPI-1, an ETS family transcriptional regulator. We show here that the expression of either SPI-1 or GP55 with the mouse EPOR in avian primary erythroblasts only marginally aects their normal Epo-induced terminal dierentiation. In contrast, the co-expression of GP55 and SPI-1 resulted in inhibition of Epo-induced dierentiation of EPOR-expressing erythroblasts, promoting instead their proliferation. Co-expression of SPI-1 and GP55 also inhibited the apoptotic cell death program normally induced in response to Epo withdrawal. This cooperation between SPI-1 and GP55 to induce primary erythroblast transformation suggests that progression of Friend erythroleukemia critically depends upon inter-dependent interactions between the molecular events speci®c of the early and late phase of the disease. Oncogene (2000) 19, 5106 ± 5110.
Friend erythroleukemia induced in mice by the spleen focus forming virus (SFFV) is a multi-step process. The pre-leukemic phase of the disease results from the abnormal activation of the Erythropoietin (Epo) receptor by the gp55 env gene product of SFFV. Later in disease progression, the emergence of leukemic clones is associated with recurrent genetic events, in particular the activation of the expression of SPI-1, an ETS family transcriptional regulator. We show here that the expression of either SPI-1 or GP55 with the mouse EPOR in avian primary erythroblasts only marginally aects their normal Epo-induced terminal dierentiation. In contrast, the co-expression of GP55 and SPI-1 resulted in inhibition of Epo-induced dierentiation of EPOR-expressing erythroblasts, promoting instead their proliferation. Co-expression of SPI-1 and GP55 also inhibited the apoptotic cell death program normally induced in response to Epo withdrawal. This cooperation between SPI-1 and GP55 to induce primary erythroblast transformation suggests that progression of Friend erythroleukemia critically depends upon inter-dependent interactions between the molecular events speci®c of the early and late phase of the disease. Oncogene (2000) 19, 5106 ± 5110.
Keywords: Friend erythroleukemia; SPI-1/PU.1; SFFV GP55; erythropoietin receptor; oncogene cooperation The development and terminal dierentiation of erythroblasts beyond the CFU-E stage is critically dependent upon Erythropoietin (Epo) and its receptor (EPOR) (Wu et al., 1995; Lin et al., 1996) . The binding of Epo leads to the activation of the EPOR-associated JAK2 tyrosine kinase (Witthuhn et al., 1993) , resulting in the phosphorylation of JAK2 itself and of the intracellular domain of EPOR on several tyrosine residues. Once phosphorylated, these tyrosine residues allow the recruitment and activation of a number of downstream adaptors and eectors including STAT5, PI-3 kinase, SHIP, the tyrosine phosphatase SHP-1 and SHP-2 and the ERK, JNK and p38 MAPkinases (for review, see Klingmuller, 1997) .
The acute erythroleukemia caused by the Spleen Focus Forming Virus (SFFV) is a well studied example of multistep tumorigenesis in adult mouse. Both the FV-A (non polycythemic) and FV-P (polycythemic) strains of SFFV induce erythroleukemia and the only viral protein required for leukemogenicity is their GP55 envelope glycoprotein (for review, see Ben-David and Bernstein, 1991) . The GP55 of both FV-A and FV-P modify the signaling properties of EPOR but activation by GP55(A) is weaker or quantitatively distinct from that induced by GP55(P) (Hankins, 1980; Ruscetti et al., 1990; Constantinescu et al., 1998) . The leukemic phase of the disease is characterized by two recurrent genetic alterations. The ®rst is the integration of an SFFV provirus at the Spi-1 locus resulting in the overexpression of an otherwise unaltered SPI-1/PU.1 protein, a transcription factor of the ETS family and the second is the inactivation of the p53 tumor suppressor gene (for review, see Ben-David and Bernstein, 1991) . The F-MuLV helper virus also induces erythroleukemia in newborn mice. In about 75% of the cases, the emergence of proliferating erythroblasts in infected animals is concomitant with the rearrangement of the Fli-1 locus and the activation of the expression of FLI-1, another member of the ETS family (for review, see Ben-David and Bernstein, 1991) .
Several lines of evidence indicate that SPI-1 and FLI-1 activation plays a central role in Friend virusesinduced erythroleukemia. The enforced expression of FLI-1 in primary avian erythroblasts or in a MEL cellline is sucient to block Epo-induced dierentiation and to convert this normal response into sustained proliferation (Pereira et al., 1999; Tamir et al., 1999) . The expression of SPI-1 to high levels induces a multistep erythroleukemia in transgenic mice (MoreauGachelin et al., 1996) and inhibits chemically-induced hemoglobinization in MEL cells (Rao et al., 1997) . However, SPI-1 was found to inhibi Epo-induced dierentiation of primary avian erythroblasts only when co-expressed with a constitutively dimerized mutant of EPOR, EPOR(R129C) (Tran Quang et al., 1997) . Substitution of Cysteine residue 129 into Arginine in the extracellular domain of EPOR results in its constitutive dimerization and in the ligandindependent activation of its signaling properties (Longmore et al., 1994) . This suggested that the transforming properties of SPI-1 depend upon signals speci®c of this mutant receptor that could mimick those speci®c of GP55-activated EPOR (Tran Quang et al., 1997) . We report here that transformation of primary avian erythroblasts by SPI-1 indeed depends upon its co-expression with GP55.
To express GP55 and/or SPI-1 we used a retroviral vector which allows both the expression of exogenous cDNAs from an internal CMV promoter and the selection of transduced cells by the presence of a gagneo fusion gene ( Figure 1A ). Derivatives encoding either GP55(A) or allowing the co-expression of GP55(A) and SPI-1 were constructed as detailed in Figure 1 legend. To produce infectious viral particles from these replication-defective retroviral genomes and to express the mouse EPOR in avian cells, we used a derivative of the replication-competent R-CAS retroviral vector construct containing the mouse EPOR cDNA ( Figure 1A ). As shown previously, the replication defectiveness of CRNCM derivatives is eciently rescued following their co-transduction with RCASEpoR in chicken ®broblasts (Tran Quang et al., 1997) . Expression of the expected proteins in virus-producing ®broblasts was analysed by immunoprecipitation using antiserum speci®c for either the mouse EPOR, or GP55 or SPI-1. The results of Figure 1B show that all combinations of RCAS-EpoR and CRNCM-derived retroviral vectors resulted in the co-expression of the expected proteins.
To study the eects of GP55 and of the combined expression of GP55 and SPI-1 on the response of primary erythroblasts to Epo, bone marrow cells were co-transduced with the respective virus stocks plus the ts-v-Sea retrovirus. Infected erythroblasts were selected in the presence of G418 as described previously (Tran Quang et al., 1997) and immunoprecipitation analyses showed that the respective clones expressed the expected proteins (Figure 2A ). The ts-v-Sea virus allows the speci®c development of erythroblast colonies in semi-solid medium and the further expansion of these cells in liquid medium at the permissive temperature (378C). Upon shift to 428C to inactivate the temperature-sensitive (ts) v-Sea kinase, these erythroblasts are induced to terminally dierentiate into fully mature erythrocytes in 3 ± 4 days in response to Epo (Knight et al., 1988) .
In accordance with previous studies (Steinlein et al., 1994) , EPOR-expressing erythroblasts terminally dierentiated in response to hEpo as evidenced by their exit from the cell cycle 2 days after dierentiation induction (Figure 3 ), their accumulation of high levels of hemoglobin ( Figure 2C ) and the acquisition of the morphology of fully mature erythrocytes ( Figure 2B ). In the absence of hEpo these cells rapidly died by apoptosis (Tran Quang et al., 1997) , as evidenced by the accumulation of cellular debris 2 days after dierentiation induction ( Figure 2B ). Erythroblast clones co-expressing GP55(A) and EPOR also dierentiated terminally in response to hEpo as shown by their morphology ( Figure 2B ) and their accumulation of high levels of hemoglobin The exogenous cDNA were inserted downstream of the CMV promoter (black box) of the CRNCM retroviral vector (Steinlein et al., 1994) . The GP55 cDNA was retrieved from pUC9 SFFV-A (Wol and Ruscetti, 1985) by EagI-ClaI digestion and bordered by MfeI and XbaI restriction enzyme sites by subcloning into an appropriate Bluescript derivative. After MfeI and XbaI digestion, the gp55 cDNA was subcloned into EcoRI and XbaI-digested pCRNCM or upstream of the IRES of ClaI2-IRES-spi-1 (Tran Quang et al., 1997) . The resulting gp55-IRES-spi-1 cassette was excised by ClaI digestion and inserted into ClaI-restricted CRNCM. The CRNCM-spi-1 and the RCAS-EPOR constructs were described (Tran Quang et al., 1997) . (B) Expression of SPI-1, GP55 and mouse EPOR in infected ®broblasts. Secondary chicken ®broblasts were co-transfected with the indicated combinations of retroviral constructs (top) and infected cells selected in 400 mg/ml G418. Infected cells were labeled with L- S-Cysteine and cell lysates subjected to immunoprecipitation analyses using the same antibodies as described in the legend of Figure 1 . Immunoprecipitates were analysed by electrophoresis on polyacrylamide gels in the presence of SDS, followed by¯uorography. Speci®cally immunoprecipitated proteins are indicated by arrowheads. (B) Morphology of ts-v-Sea erythroblasts clones expressing EPOR alone (#B10), EPOR/GP55 (#D8), EPOR/SPI-1 (#B1) or EPOR/GP55/SPI-1 (#B6). Pictures show clones maintained at 428C in the absence or presence of hEpo (Ins or Ins+hEpo, respectively) for 2 days (EPOR and EPOR/ GP55, top panels) or for 3 days (EPOR, EPOR/GP55, EPOR/SPI-1 and EPOR/GP55/SPI-1, intermediate and bottom panels). Erythroblasts were seeded in dierentiation medium and incubated at 428C in the presence of 1.4 nM insulin or a combination of insulin and recombinant human Epo (1 U/ml; a generous gift of Janssen-Cilag), as described previously (Tran Quang et al., 1997) . Aliquots of dierentiation-induced cells were cytocentrifuged onto slides, stained with neutral benzidine (stains hemoglobin in brown) and Giemsa. (C) Quantitative determination of hemoglobin levels in erythroblasts clones expressing EPOR alone (#B10 and #C4), EPOR/GP55 (#D8 and #D9), EPOR/SPI-1 (#A2 and #B1), or EPOR/GP55/SPI-1 (#B6 and #C6). Analyses were done 2 and 3 days after shift to 428C in insulin (white bars) or insulin plus hEpo (black bars). Photometric hemoglobin assay was carried out as described previously (Tran Quang et al., 1997 ). Normalized values (hemoglobin level per 10 6 live cells at day 2 and 3) are shown ( Figure 2C ). In the absence of hEpo, EPOR/GP55 clones showed enhanced survival as compared to EPOR-only expressing clones as evidenced by the presence of 40 ± 50% (depending on the clone considered) morphologically intact cells 2 days after shift to 428C and the maintenance of 10 ± 30% live cells after 3 days ( Figure 2B ). Under these conditions, EPOR/GP55 clones acquired the morphology of incompletely dierentiated cells ( Figure 2B ) and accumulated hemoglobin, albeit at a lower level than that observed in response to hEpo ( Figure 2C ). We conclude that GP55(A) does not interfere with the Epo-dependent dierentiation program of primary avian erythroblasts. Rather, GP55(A) partially mimicked the eect of hEpo to induce the incomplete dierentiation of these cells. These results are in accordance with recent data showing that expression of either GP55(A) or GP55(P) in d12.5 fetal liver mouse cells induces the formation of CFU-E colonies in the absence of exogenous Epo of a size smaller than that observed in response to Epo (Constantinescu et al., 1998) . The results of Figures 2 and 3 show that the expression of SPI-1 in EPOR/GP55 erythroblasts profoundly altered their normal survival and dierentiation control. In the presence of hEpo, these clones showed only a slight increase in hemoglobin content ( Figure 2C ; 2 ± 3-fold at day 3 as compared to the 412-fold increase seen in EPOR/GP55 erythroblasts) and remained immature as shown by their erythroblastic morphology and their lack of benzidine staining ( Figure 2B ). In these conditions, EPOR/GP55/SPI-1 erythroblasts self-renewed as differentiation-arrested cells (Figure 3) . In addition to its inhibitory eect on hEpo-induced dierentiation, SPI-1 expression was also found to enhance the survival of EPOR/GP55 erythroblasts in the absence of hEpo. Indeed, in contrast to EPOR/GP55 erythroblasts, EPOR/GP55/SPI-1 cells retained a large proportion of healthy, immature cells in the absence of hEpo (see Figure 2B , Ins panels). This eect of SPI-1 on cell survival is corroborated in TUNEL assays by the reduction of TdT-positive, apoptotic cells in EPOR/ GP55/SPI-1 erythroblasts as compared to EPOR/ GP55 cells (20 ± 30% TdT+ cells in EPOR/GP55/ SPI-1 erythroblasts vs 50 ± 60% TdT+ cells in EPOR/GP55 cells after 24 h in absence of hEpo). We conclude from these experiments that SPI-1 arrests the hEpo-induced dierentiation of EPOR/ GP55 erythroblasts to convert this normal response into sustained proliferation and enhances their survival in the absence of hEpo. In contrast and as previously shown (Tran Quang et al., 1997) , erythroblasts co-expressing SPI-1 with EPOR alone dierentiated terminally in response to hEpo ( Figure  2B,C) . The eects of SPI-1 on the proliferation and dierentiation control of erythroblasts depends therefore upon its co-expression with GP55. 6 cell/ml, shifted to 428C and counted daily using an electronic cell counter (CASY, SchaÈ rfe System, Germany). Cultures were maintained at a density between 1 and 3610 6 cells/ml by appropriate dilution in the respective media. Cumulative cell numbers were plotted over time
The molecular mechanisms involved in the response of erythroblasts to GP55 are ill-understood. Although only GP55(P) appears to form a stable complex with EPOR, the response of erythroblasts to both the GP55(A) and (P) depends upon EPOR since these glycoproteins failed to induce erythroid colony formation in fetal liver cells derived from homozygous EpoR7/7 embryos (Constantinescu et al., 1998) . In addition, recent evidence indicates that the EPOR/ GP55 signaling complex may also include a truncated variant of the RON tyrosine kinase (Persons et al., 1999) . Our results suggest that a critical signal(s) emanating from this large signaling complex cooperates with SPI-1 to transform erythroblasts. This signal could either directly or indirectly regulate the activity of SPI-1. Direct eects could involve the regulation of SPI-1 phosphorylation either on identi®ed sites (Pongubala et al., 1993) or on novel residues in domains critical for its activity. Alternatively, these signals could regulate the expression or activity of a SPI-1 co-factor. Recent evidence has shown that the expression of GP55(A) and (P) induces the constitutive activation of the RAF/MEK/ERK pathway in erythroblasts and the expression of several AP1 components, including c-JUN (Muszynski et al., 1998) . Interestingly, c-JUN has recently been shown to function as a SPI-1 co-activator in transient reporter gene assays (Behre et al., 1999) . Alternatively, the cooperation between SPI-1 and GP55 could involve the activation of parallel pathways acting in synergy to modify the cellular phenotype.
The cooperation between SPI-1 and GP55 observed here is consistent with the fact that the activation of SPI-1 in SFFV-induced erythroleukemia is always and speci®cally preceded by the abnormal engagement of the EPOR due to its interaction with GP55 (for review, see Ben-David and Bernstein, 1991) . This appears at variance with the erythroleukemia induced in a SPI-1 transgenic mouse model in which SPI-1 is proposed to act on its own to transform erythroblasts (MoreauGachelin et al., 1996) . However, in this latter model, erythroleukemia only develops after a signi®cantly longer latency than the SFFV-induced disease and only in transgenic sublines expressing massive amounts of SPI-1, suggesting that high levels expression of SPI-1 can bypass the requirement for EPOR/GP55-derived signals in erythroblast transformation. Of note, recent evidence indicates that the level of SPI-1/PU.1 expression is essential to direct the fate of myeloid progenitors during normal mouse development (DeKoter and Singh, 2000) . In addition, in the SPI-1 transgenic model, the emergence of tumorigenic clones (a property of bona ®de Friend leukemic cells; MoreauGachelin et al., 1988; for review, see Ben-David and Bernstein, 1991) only occurs after experimental hypertransfusion of transgenic animals, suggesting that cooperation of SPI-1 with other molecular events, some of them possibly acting downstream of EPOR, is required at this stage as well.
